Back to Search
Start Over
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma.
- Source :
-
Journal of Experimental & Clinical Cancer Research (17569966) . 9/30/2023, Vol. 42 Issue 1, p1-1. 1p. - Publication Year :
- 2023
-
Abstract
- Supplementary Information The online version contains supplementary material available at https://doi.org/10.1186/s13046-023-02824-9. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. [Extracted from the article]
- Subjects :
- *CANCER invasiveness
*CELLULAR signal transduction
*LINCRNA
*NEOVASCULARIZATION
Subjects
Details
- Language :
- English
- ISSN :
- 17569966
- Volume :
- 42
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Journal of Experimental & Clinical Cancer Research (17569966)
- Publication Type :
- Academic Journal
- Accession number :
- 172443937
- Full Text :
- https://doi.org/10.1186/s13046-023-02824-9